Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Commercially available Angiotensin II AT1 receptor antibodies are widely employed for receptor localization and quantification, but they have not been adequately validated. In this study, six commercially available AT1 receptor antibodies were characterized by established criteria: sc-1173 and sc-579 from Santa Cruz Biotechnology, Inc., AAR-011 from Alomone Labs, Ltd., AB15552 from Millipore, and ab18801 and ab9391 from Abcam. The immunostaining patterns observed were different for every antibody tested, and were unrelated to the presence or absence of AT1 receptors. The antibodies detected a 43 kDa band in western blots, corresponding to the predicted size of the native AT1 receptor. However, identical bands were observed in wild-type mice and in AT1A knock-out mice not expressing the target protein. Moreover, immunoreactivity detected in rat hypothalamic 4B cells not expressing AT1 receptors or transfected with AT1A receptor construct was identical, as revealed by western blotting and immunocytochemistry in cultured 4B cells. Additional prominent immunoreactive bands above and below 43 kDa were observed by western blotting in extracts from tissues of AT1A knock-out and wild-type mice and in 4B cells with or without AT1 receptor expression. In all cases, the patterns of immunoreactivity were independent of the AT1 receptor expression and different for each antibody studied. We conclude that, in our experimental setup, none of the commercially available AT1 receptor antibodies tested met the criteria for specificity and that competitive radioligand binding remains the only reliable approach to study AT1 receptor physiology in the absence of full antibody characterization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924 · cited 1×
“In particular, there is an increasing interest on its main active component, Angiotensin II (Ang II), and on its physiological AT1 receptor type (Mehta and Griendling 2007; Bader 2010; Paul et al. 2006; Saavedra et al. 2011), Rodents express two AT1 receptor subtypes, the AT1A and AT1B receptors (Sasamura et al.”
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306 · cited 2×
“devoid of target protein allowed the definitive determination of antibody specificity, a necessary condition to insure that results are replicable and likely to be correct (Saper and Sawchenko 2003; Saper 2005, 2009; Rhodes and Trimmer 2006; Lorincz and Nusser 2008; Michel et al. 2009).”
Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific
Jensen, B. C., Swigart, P. M., & Simpson, P. C. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-008-0368-6 · Cited by 176
Antibodies as valuable neuroscience research tools versus reagents of mass distraction
Rhodes, K. J., & Trimmer, J. S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2728-06.2006 · Cited by 162
Pradidarcheep, W., Stallen, J., Labruyère, W. T., Dabhoiwala, N. F., Michel, M. C., & Lamers, W. H. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0393-0 · Cited by 152 · cited 1×
“…of a large number of G-protein-coupled receptor antibodies, including muscarinic , adrenergic, galanin, and dopamine receptors (Jositsch et al. 2009; Jensen et al. 2009; Bodei et al. 2009; Hamdani and van der Velden 2009; Lu and Bartfai 2009; Michel et al. 2009; Pradidarcheep et al. 2009).”
Cited by
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Daugherty, A., Tall, A. R., Daemen, M. J. A. P., Falk, E., Fisher, E. A., García-Cardeña, G., Lusis, A. J., Owens, A. P., Rosenfeld, M. E., & Virmani, R. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000062 · Cited by 316
Kehoe, P. G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171119 · Cited by 133
de Kloet, A. D., Liu, M., Rodríguez, V., Krause, E. G., & Sumners, C. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00078.2015 · Cited by 64
“These efforts have been somewhat complicated by the unreliability of angiotensin receptor antibodies (9, 73, 79) and the poor cellular resolution of angiotensin receptor autoradiography techniques.”
BackgroundHaxho, F., Haq, S., & Szewczuk, M. R. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2017.12.006 · Cited by 42
Metadata
- Authors
- Benicky, J., Hafko, R., Sanchez-Lemus, E., Aguilera, G., & Saavedra, J. M.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2012-07-28
- Volume
- 32
- Issue
- 8
- Pages
- 1353-1365
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- OpenAlex
- W2061069000
- Cited by
- 112
- References
- 6
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific. https://app.cochat.ai/papers/10.1007/s10571-012-9862-y
- The paper
- Benicky, J., Hafko, R., Sanchez-Lemus, E., Aguilera, G., & Saavedra, J. M. (2012). Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-012-9862-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.